Tella Pharma Inc.

Research, development / testing, manufacturing, contract manufacturing, etc. of pharmaceuticals, medical devices, regenerative medicine products, etc.

We are promoting research and development of products such as regenerative medicine for the treatment of intractable cancer based on dendritic cell vaccine technology that utilizes the cancer immune response. Aiming to obtain approval as a product for regenerative medicine of dendritic cell vaccine, we are providing clinical trial products for clinical trials targeting pancreatic cancer.

電話アイコン +81-44-200-4150
メールアイコン nkuroiwa@tella-pharma.com

LIC

Regenerative Medicine

  • Drug Discovery/Drug Discovery Support